The abortion drugs market is estimated to be valued at US$ 3.53 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Abortion drugs refers to medications that induce abortion. The commonly used abortion drugs includes mifepristone and misoprostol. Mifepristone blocks progesterone, which is ... Read more

Abortion drugs refer to medicines used to induce an abortion. Various abortion pills available in the market include Mifepristone, Misoprostol, and Methotrexate among others. These drugs are used to terminate early pregnancies. They are prescribed by doctors and dispensed by licensed pharmacies to patients who wish to terminate their pregnancy. The global abortion drugs market is gaining traction owing to the rising public awareness regarding reproductive health and rights, safety and ... Read more

The abortion drugs market comprises medications that are specifically used to induce abortion during early pregnancy. Mifepristone and misoprostol are the key abortion drugs available in the market. These drugs work by blocking the hormone progesterone, thereby thickening the lining of the uterus and inducing abortion. The rising demand for non-invasive procedures along with the legalization of abortion in various countries is driving the growth of the abortion drugs market. The ... Read more